Protecting Lifestyle and Legacy with TD Insurance Private Client Advice

Canada NewsWire

Launch of personalized advisor group for in-demand specialized and custom protection for affluent Canadians

TORONTO, July 21, 2021 /CNW/ – The new TD Insurance Private Client Advice is Canada’s first comprehensive direct-to-consumer insurance service designed to better protect affluent Canadians and their families with a sophisticated insurance advisor experience.

“Preserving wealth is as critically important as creating it for many of our clients and often is one of their most neglected financial goals,” says James Russell, President and CEO, TD Insurance. “Many Canadians who require customized insurance protection have been underserved and, as a result, underinsured. TD Insurance Private Client Advice is a highly specialized direct-to-consumer service designed to remove the complexity of understanding and purchasing multiple insurance products from different insurers that can unintentionally create gaps between needs and coverage, leaving people at risk.”

Private Client Advice customers get greater peace of mind knowing they are working with highly experienced and dedicated insurance advisors who specialize in providing guidance to assess and manage sophisticated protection issues that are as unique as each client. Our claims service offers a seamless experience that includes a dedicated Claims Specialist and an exclusive network of TD Insurance Auto Centres to start repairs quickly.

“TD Insurance Private Client Advice will further help provide clients with goals-based financial plan discussions,” says Paul Clark, Executive Vice President, TD Bank Group & Head of Private Wealth Management and Financial Planning. “Together, TD will provide comprehensive wealth management advice that includes building net worth, implementing tax-efficient strategies and leaving a legacy, combined with tailored insurance services through an exceptional Private Client Advice experience that will help protect what matters most to clients.”

Coverage is also about safeguarding the comfort and enjoyment our clients get from what’s insured. High-net-worth clients often face greater risks to their lifestyle, wealth and most-valued possessions in the event of a significant personal or professional loss. From home and auto to artwork and jewellery coverage, our Private Client Advice team has the expertise to handle all aspects of our client’s portfolios in areas that are often not sufficiently covered by conventional insurance policies.

TD Insurance Private Client Advice services include:

  • Homeowner’s insurance, as well as coverage for cottages and chalets
  • Personal excess liability
  • Coverage of valuable articles such as wine collections, art collections, and jewellery
  • Automobile and recreational vehicle insurance
  • Yacht and watercraft insurance
  • Cross-border insurance
  • Cyber and fraud insurance
  • Complimentary home appraisal for loss prevention

To learn more about TD Insurance Private Client Advice or reach an advisor to set up an appointment, please visit www.tdinsurance.com/privateclientadvice.

About TD Bank Group

The Toronto-Dominion Bank and its subsidiaries are collectively known as TD Bank Group (“TD” or the “Bank”). TD is the fifth largest bank in North America by assets and serves over 26 million customers in three key businesses operating in a number of locations in financial centres around the globe: Canadian Retail, including TD Canada Trust, TD Auto Finance Canada, TD Wealth (Canada), TD Direct Investing, and TD Insurance; U.S. Retail, including TD Bank, America’s Most Convenient Bank®, TD Auto Finance U.S., TD Wealth (U.S.), and an investment in The Charles Schwab Corporation; and Wholesale Banking, including TD Securities. TD also ranks among the world’s leading online financial services firms, with more than 15 million active online and mobile customers. TD had CDN$1.7 trillion in assets on April 30, 2021. The Toronto-Dominion Bank trades under the symbol “TD” on the Toronto and New York Stock Exchanges.

TD Insurance refers collectively to the following personal lines insurance companies within TD Bank Group: Security National Insurance Company, Primmum Insurance Company, TD General Insurance Company, TD Home and Auto Insurance Company and TD Life Insurance Company

SOURCE TD Insurance

BMO Global Asset Management Announces Cash Distributions for Certain BMO Exchange Traded Funds

Canada NewsWire

TORONTO, July 21, 2021 /CNW/ – BMO Asset Management Inc. today announced the July 2021 cash distributions for BMO Exchange Traded Funds (BMO ETFs) that distribute monthly. Unitholders of record of the BMO ETFs at the close of business on July 29th, 2021 will receive cash distributions payable on August 4th, 2021.

Details of the per-unit cash distribution amount are as follows:


Monthly Distributions


Ticker


Cash
Distribution
per Unit ($)

BMO Aggregate Bond Index ETF

ZAG

0.040

BMO Discount Bond Index ETF

ZDB

0.030

BMO Ultra Short-Term Bond ETF

ZST

0.090

BMO Ultra Short-Term US Bond ETF (U.S. Dollar Units)

ZUS.U

0.090

BMO Short Federal Bond Index ETF

ZFS

0.022

BMO Mid Federal Bond Index ETF

ZFM

0.028

BMO Long Federal Bond Index ETF

ZFL

0.043

BMO Real Return Bond Index ETF

ZRR

0.032

BMO Short Provincial Bond Index ETF

ZPS

0.032

BMO Mid Provincial Bond Index ETF

ZMP

0.034

BMO Long Provincial Bond Index ETF

ZPL

0.045

BMO Short Corporate Bond Index ETF

ZCS

0.035

BMO Mid Corporate Bond Index ETF

ZCM

0.046

BMO Long Corporate Bond Index ETF

ZLC

0.065

BMO Short-Term US IG Corporate Bond Hedged to CAD Index ETF

ZSU

0.035

BMO Mid-Term US IG Corporate Bond Index ETF

ZIC

0.055

BMO Mid-Term US IG Corporate Bond Index ETF (U.S. Dollar Units)

ZIC.U

0.045

BMO Mid-Term US IG Corporate Bond Hedged to CAD Index ETF

ZMU

0.045

BMO High Yield US Corporate Bond Hedged to CAD Index ETF

ZHY

0.060

BMO High Yield US Corporate Bond Index ETF

ZJK

0.090

BMO Floating Rate High Yield ETF

ZFH

0.055

BMO Emerging Markets Bond Hedged to CAD Index ETF

ZEF

0.050

BMO Laddered Preferred Share Index ETF

ZPR

0.045

BMO US Preferred Share Index ETF

ZUP

0.110

BMO US Preferred Share Index ETF (U.S. Dollar Units)

ZUP.U

0.110

BMO US Preferred Share Hedged to CAD Index ETF

ZHP

0.110

BMO Monthly Income ETF

ZMI

0.055

BMO Canadian High Dividend Covered Call ETF

ZWC

0.100

BMO Covered Call Canadian Banks ETF

ZWB

0.100

BMO Covered Call US Banks ETF

ZWK

0.180

BMO Covered Call Utilities ETF

ZWU

0.080

BMO Covered Call Dow Jones Industrial Average Hedged to CAD ETF

ZWA

0.100

BMO US High Dividend Covered Call ETF

ZWH

0.110

BMO US High Dividend Covered Call ETF (U.S. Dollar Units)

ZWH.U

0.115

BMO US High Dividend Covered Call Hedged to CAD ETF

ZWS

0.105

BMO Europe High Dividend Covered Call ETF

ZWP

0.090

BMO Europe High Dividend Covered Call Hedged to CAD ETF

ZWE

0.100

BMO US Put Write ETF

ZPW

0.095

BMO US Put Write ETF (U.S. Dollar Units)

ZPW.U

0.095

BMO US Put Write Hedged to CAD ETF

ZPH

0.100

BMO Canadian Dividend ETF

ZDV

0.065

BMO US Dividend ETF

ZDY

0.075

BMO US Dividend ETF (U.S. Dollar Units)

ZDY.U

0.065

BMO US Dividend Hedged to CAD ETF

ZUD

0.060

BMO International Dividend ETF

ZDI

0.065

BMO International Dividend Hedged to CAD ETF

ZDH

0.070

BMO Equal Weight Banks Index ETF

ZEB

0.100

BMO Equal Weight Utilities Index ETF

ZUT

0.070

BMO Equal Weight REITs Index ETF

ZRE

0.090

BMO Global High Dividend Covered Call ETF

ZWG

0.170

BMO Canadian MBS Index ETF

ZMBS

0.040

BMO Premium Yield ETF

ZPAY

0.160

BMO Premium Yield ETF (U.S. Dollar Units)

ZPAY.U

0.160

BMO Premium Yield ETF (Hedged Units)

ZPAY.F

0.160

BMO Covered Call Technology ETF

ZWT

0.130

BMO ESG High Yield US Corporate Bond Index ETF

ESGH

0.120

BMO ESG High Yield US Corporate Bond Index ETF (Hedged Units)

ESGH.F

0.120

BMO High Yield US Corporate Bond Index ETF (U.S. Dollar Units)

ZJK.U

0.090

Further information about BMO ETFs can be found at www.bmo.com/etfs.

The Dow Jones Industrial Average Index CAD Hedged is a product of Dow Jones Opco, LLC (“Dow Jones Opco”), a subsidiary of S&P Dow Jones Indices LLC, and has been licensed for use.
“Dow Jones®” and “Industrial Average Index CAD Hedged” are service marks of Dow Jones Trademark Holdings, LLC (“Dow Jones”), and have been licensed to Dow Jones Opco and sublicensed by BMO Asset Management Inc. in connection with ZWA. ZWA is not sponsored, endorsed, sold or promoted by Dow Jones Opco, Dow Jones and their respective affiliates, and they make no representation regarding the advisability of trading or investing in ZWA.

®/™Registered trademarks/trademark of Bank of Montreal, used under licence.

BMO Global Asset Management is a brand name that comprises BMO Asset Management Inc., BMO Investments Inc., BMO Asset Management Corp., BMO Asset Management Limited and BMO’s specialized investment management firms.

BMO ETFs are managed by BMO Asset Management Inc., which is an investment fund manager and a portfolio manager, and a separate legal entity from Bank of Montreal.

Commissions, management fees and expenses (if applicable) all may be associated with investments in BMO ETFs.  Please read the ETF Facts or prospectus of the relevant BMO ETF before investing.  BMO ETFs are not guaranteed, their values change frequently and past performance may not be repeated.

For a summary of the risks of an investment in the BMO ETFs of the BMO Mutual Funds, please see the specific risks set out in the prospectus.  BMO ETFs trade like stocks, fluctuate in market value and may trade at a discount to their net asset value, which may increase the risk of loss. Distributions are not guaranteed and are subject to change and/or elimination.

About BMO Exchange Traded Funds (ETFs)
BMO Exchange Traded Funds has been a leading ETF provider in Canada for more than 11 years, with over 100 strategies, over 25 per cent market share in Canada1, and $80.6 billion in assets under management. BMO ETFs are designed to stay ahead of market trends and provide compelling solutions to help advisors and investors. This includes a comprehensive suite of ETFs developed in Canada for Canadians, such as cost effective core equity ETFs following market leading indexes, and a broad range of fixed income ETFs; solution-based ETFs responding to client demand; and innovation with smart beta ETFs, as well as combining active and passive investing with ETF series of active mutual funds.

1Morningstar, May 2021

About BMO Financial Group 
Serving customers for 200 years and counting, BMO is a highly diversified financial services provider – the 8th largest bank, by assets, in North America. With total assets of $950 billion as of April 30, 2021, and a team of diverse and highly engaged employees, BMO provides a broad range of personal and commercial banking, wealth management and investment banking products and services to more than 12 million customers and conducts business through three operating groups: Personal and Commercial Banking, BMO Wealth Management and BMO Capital Markets.

SOURCE BMO Financial Group

Atlas Announces Second Quarter 2021 Results Conference Call and Webcast

PR Newswire

LONDON, July 21, 2021 /PRNewswire/ – Atlas Corp. (“Atlas”) (NYSE: ATCO) plans to release its financial results for the quarter ended June 30, 2021, after the market close on Monday, August 9, 2021. Atlas plans to host a conference call for all shareholders and interested parties at 8:30 a.m. Eastern Time (ET) on Tuesday, August 10, 2021, to discuss the results.

Conference Call and Webcast Information:

Date of Conference Call:

Tuesday, August 10, 2021

Scheduled Time:

08:30 a.m. ET

US/Canada Toll Free Dial-In:

+1 (877) 246-9875

International Dial-In:

+1 (707) 287-9353

Listen Only Toll-Free Dial in Number:

+1 (888) 556-5741

Listen Only International Dial In Number:

+1 (857) 270-6226

Conference ID:

2941786

To access the live webcast of the conference call, go to atlascorporation.com and click on “Investor Relations” then “Events & Presentations” for the link. The webcast will be archived on the website for one year.

A replay will be available approximately two hours following the conclusion of the call and accessible until August 25, 2021. The replay telephone numbers are: US/Canada +1 (855) 859-2056 and International +1 (404) 537-3406, and the replay passcode is: 2941786.

About Atlas 
Atlas is a leading global asset management company, differentiated by its position as a best-in class owner and operator with a focus on deploying capital to create sustainable shareholder value. Atlas brings together an experienced asset management team with deep operational and capital allocation experience. We target long-term, risk adjusted returns across high quality infrastructure assets in the maritime sector, energy sector and other infrastructure verticals. Our two portfolio companies, Seaspan Corporation and APR Energy Ltd. are unique, industry-leading operating platforms in the global maritime and energy spaces, respectively. For more information visit atlascorporation.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/atlas-announces-second-quarter-2021-results-conference-call-and-webcast-301338510.html

SOURCE Atlas Corp.

S&P Global Platts and ICE Issue Joint Paper and Open Market Consultations on the Evolution of the Brent Complex

PR Newswire

LONDON, July 21, 2021 /PRNewswire/ — S&P Global Platts (“Platts”), the leading independent provider of information, analytics, and benchmark prices for the commodities and energy markets, and Intercontinental Exchange, Inc. (NYSE:ICE), a leading global provider of data, technology, and market infrastructure, today published a joint white paper and launched simultaneous consultations on the evolution of the Brent complex, which includes Dated Brent, Cash Brent, and ICE Brent Crude Oil futures.

The paper, co-authored by Platts and ICE which oversee, respectively, the Dated Brent physical benchmark price assessment and the ICE Brent Crude Oil futures contract, provides an overview of options for adding additional deliverable crude oil to the Brent complex and outlines a number of key issues and questions as it seeks market feedback.

Ongoing discussions conducted separately by ICE and Platts have demonstrated that industry opinion has focused specifically on two possible streams of crude to become part of Dated Brent. The first is Johan Sverdrup as a deliverable option under the Forward Brent contract, which would remain on a Free on Board (“FOB”) basis. The second is West Texas Intermediate (WTI) Midland, which would be a deliverable grade on an FOB USGC basis.

“In publishing this paper, Platts and ICE ensure the market gets to hear the key themes regarding the evolution of the entire Brent complex, from the physical elements of Dated Brent itself and related assessments to financial futures,” said Joel Hanley, Global Director, Crude & Fuel Oil Markets, S&P Global Platts. “We look forward to engaging with market participants and ensuring the smooth transition to the next phase of Brent’s journey at Platts.”

“Key to Brent’s multi-decade success as the global crude oil benchmark, has been its ability to evolve, and we look forward to ongoing discussions with customers as we navigate this next phase of its evolution with Platts,” said Jeff Barbuto, Global Head of Oil Markets at ICE. “Our goal for this consultation is to facilitate a discussion with market participants covering all of the key issues which need to be addressed so that we can strengthen the Brent complex for decades to come.”

The white paper discusses a common set of identified issues and questions around the possible inclusion of the Johan Sverdrup and WTI Midland streams. Platts and ICE have today announced market consultations through Platts’ Subscriber Notes and ICE’s Circular to solicit feedback. All interested parties are encouraged to provide feedback and to put forward any further relevant items through the respective consultation feedback channels. The deadline for comments is September 30, 2021.

About S&P Global Platts

At S&P Global Platts, we provide the insights; you make better informed trading and business decisions with confidence. We’re the leading independent provider of information and benchmark prices for the commodities and energy markets. Customers in over 150 countries look to our expertise in news, pricing and analytics to deliver greater transparency and efficiency to markets. S&P Global Platts coverage includes oil and gas, power, petrochemicals, metals, agriculture and shipping.

S&P Global Platts is a division of S&P Global (NYSE: SPGI), which provides essential intelligence for individuals, companies and governments to make decisions with confidence. For more information, visit www.platts.com.

About Intercontinental Exchange


Intercontinental Exchange, Inc.

 (NYSE: ICE) is a Fortune 500 company that designs, builds and operates digital networks to connect people to opportunity. We provide financial technology and data services across major asset classes that offer our customers access to mission-critical workflow tools that increase transparency and operational efficiencies. We operate exchanges, including the New York Stock Exchange, and clearing houses that help people invest, raise capital and manage risk across multiple asset classes. Our comprehensive fixed income data services and execution capabilities provide information, analytics and platforms that help our customers capitalize on opportunities and operate more efficiently. At ICE Mortgage Technology, we are transforming and digitizing the U.S. residential mortgage process, from consumer engagement through loan registration. Together, we transform, streamline and automate industries to connect our customers to opportunity.

Trademarks of ICE and/or its affiliates include Intercontinental Exchange, ICE, ICE block design, NYSE and New York Stock Exchange. Information regarding additional trademarks and intellectual property rights of Intercontinental Exchange, Inc. and/or its affiliates is located here. Key Information Documents for certain products covered by the EU Packaged Retail and Insurance-based Investment Products Regulation can be accessed on the relevant exchange website under the heading “Key Information Documents (KIDS).”

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995 — Statements in this press release regarding ICE’s business that are not historical facts are “forward-looking statements” that involve risks and uncertainties. For a discussion of additional risks and uncertainties, which could cause actual results to differ from those contained in the forward-looking statements, see ICE’s Securities and Exchange Commission (SEC) filings, including, but not limited to, the risk factors in ICE’s Annual Report on Form 10-K for the year ended December 31, 2020, as filed with the SEC on February 4, 2021.

ICE- CORP
Source: Intercontinental Exchange

S&P Global Platts Contact:

Kathleen Tanzy, + 1 917 331 4607
[email protected]

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/sp-global-platts-and-ice-issue-joint-paper-and-open-market-consultations-on-the-evolution-of-the-brent-complex-301338224.html

SOURCE S&P Global Platts

Orbital Energy Group, Inc. Announces $38 Million Registered Direct Offering

PR Newswire

HOUSTON, July 21, 2021 /PRNewswire/ — Orbital Energy Group, Inc. (NASDAQ: OEG) (“OEG”) today announced it has entered into a securities purchase agreement with institutional investors for the purchase and sale of 10,410,959 shares of its common stock at a purchase price of $3.65 per share in a registered direct offering. The closing of the offering is expected to occur on or about July 23, 2021, subject to the satisfaction of customary closing conditions.

A.G.P./Alliance Global Partners is acting as sole placement agent for the offering.

This offering is being made pursuant to an effective shelf registration statement on Form S-3 (File No. 333-252682) previously filed with the U.S. Securities and Exchange Commission (the “SEC”). A prospectus supplement describing the terms of the proposed offering will be filed with the SEC and will be available on the SEC’s website located at http://www.sec.gov. Electronic copies of the prospectus supplement may be obtained, when available, from A.G.P./Alliance Global Partners, 590 Madison Avenue, 28th Floor, New York, NY 10022, or by telephone at (212) 624-2060, or by email at [email protected]. Before investing in this offering, interested parties should read in their entirety the prospectus supplement and the accompanying prospectus and the other documents that the Company has filed with the SEC that are incorporated by reference in such prospectus supplement and the accompanying prospectus, which provide more information about the Company and such offering.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Orbital
Orbital Energy Group, Inc. (Nasdaq: OEG) is creating a diversified energy services platform through the acquisition and development of innovative companies. Orbital Energy’s group of businesses includes Orbital Power Services, Orbital Solar Services, Orbital Telecom Services and Orbital Gas Systems.

Orbital Power Services provides engineering, construction, maintenance and emergency response solutions to the power, utilities, and midstream markets.

Orbital Solar Services provides engineering, procurement, and construction (“EPC”) expertise in the renewable energy industry and established relationships with solar developers and panel manufacturers in the utility scale solar market.

Orbital Telecom Services, operating as Gibson Technical Services, has nationwide locations equipped to effectively support multi-vendor OEM technology environments and outside plant construction operations on an as-needed basis with specialized services in broadband, wireless, outside plant and building technologies, including healthcare. Orbital Gas Systems is a 30-year leader in innovative gas solutions, serving the energy, power and processing markets through the design, installation and commissioning of industrial gas sampling, measurement, and delivery systems.

As a publicly traded company, Orbital Energy is dedicated to maximizing shareholder value. But most important, our commitment to conduct business with a high level of integrity, respect, and philanthropic dedication allows the organization to make a difference in the lives of their customers, employees, investors, and global community.

For more information please visit: www.orbitalenergygroup.com

Forward Looking Statements
This press release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 and Private Securities Litigation Reform Act, as amended, including those relating to the timing and completion of the proposed offering and other statement that are predictive in nature.  These statements may be identified by the use of forward-looking expressions, including, but not limited to, “expect,” “anticipate,” “intend,” “plan,” “believe,” “estimate,” “potential,” “predict,” “project,” “should,” “would” and similar expressions and the negatives of those terms.  These statements relate to future events and involve known and unknown risks, uncertainties and other factors which may cause actual results, performance or achievements to be materially different from any results, performance or achievements expressed or implied by the forward-looking statements. Such factors include the risk factors set forth in the Company’s filings with the SEC, including, without limitation, its Annual Report on Form 10-K for the year ended December 31, 2020, its periodic reports on Form 10-Q, and its Current Reports on Form 8-K filed in 2020 and 2021, as well as the risks identified in the shelf registration statement and the prospectus supplement relating to the offering. Prospective investors are cautioned not to place undue reliance on such forward-looking statements, which speak only as of the date of this press release. Orbital undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise.

Investor Relations

KCSA Strategic Communications
David Hanover
T: 212-896-1220
[email protected]

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/orbital-energy-group-inc-announces-38-million-registered-direct-offering-301338069.html

SOURCE Orbital Energy Group, Inc.

SPX FLOW to Report Second Quarter 2021 Results on August 4, 2021

PR Newswire

CHARLOTTE, N.C., July 21, 2021 /PRNewswire/ — SPX FLOW, Inc. (NYSE: FLOW), a leading provider of process solutions for the nutrition, health and industrial markets, announced today its plan to report second quarter 2021 financial results on Aug. 4, 2021. During a conference call at 9 a.m. EDT, SPX FLOW President and Chief Executive Officer Marc Michael and Vice President and Chief Financial Officer Jaime Easley will discuss the company’s second quarter 2021 results. Those interested in participating in the conference call should dial in five minutes prior to the start of the call. The call will be webcast simultaneously via the company’s website at www.spxflow.com, and the slide presentation will be available in the Investor Relations section of the site. An archive of the webcast will be available through the company’s website after the call.

Conference Call:

Dial in: 877-870-4263
From outside the United States:  + 1 412-317-0790

Passcode: SPX FLOW

About SPX FLOW, Inc.:

Based in Charlotte, N.C., SPX FLOW, Inc. (NYSE: FLOW) improves the world through innovative and sustainable solutions. The company’s product offering is concentrated in process technologies that perform mixing, blending, fluid handling, separation, thermal heat transfer and other activities that are integral to processes performed across a wide variety of nutrition, health and industrial markets. SPX FLOW had approximately $1.4 billion in 2020 annual revenues and has operations in more than 30 countries and sales in more than 140 countries. To learn more about SPX FLOW, please visit www.spxflow.com.

Investor Contacts:

Scott Gaffner

VP, Investor Relations and Strategic Insights
704-752-4485
[email protected]

Media Contact:

Peter Smolowitz

External Communications Manager
[email protected]
704-390-6918

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/spx-flow-to-report-second-quarter-2021-results-on-august-4-2021-301337692.html

SOURCE SPX FLOW, Inc.

Health Catalyst Launches Value Optimizer – A New Approach to Managing Risk and Achieving Profitability in Population Health

PR Newswire

SALT LAKE CITY, July 21, 2021 /PRNewswire/ — Health Catalyst, Inc. (“Health Catalyst,”) (Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced the launch of Value Optimizer™, a new population health solution that quickly identifies highly valuable opportunities for value-based care (VBC) performance improvement. 

VBC payment models have become increasingly common as healthcare organizations seek a better approach to managing risk and achieving profitability in population health. But, while many healthcare organizations have relied on population health tools to support their VBC payment models and better understand their populations, many existing products lack the full-service data and insight capabilities to empower population health leaders optimize their VBC strategy.

Traditional population health offerings provide only black-box logic and groupers, while EHRs lack the ability to deliver granular-level revenue and utilization information about specific populations—critical information leaders need to compare the total cost of care with performance benchmarks across the care continuum. Further, the lack of data integration capabilities from these traditional tools results in partial data sets and an incomplete view of populations. It’s time for leaders to reject substandard population health results.

“Health systems are desperate to curb the rising cost of healthcare, but not at the expense of patient care and quality. It is an issue that has only been exacerbated by the COVID-19 pandemic,” said Darian Allen, SVP and General Manager, Population Health at Health Catalyst. “Value Optimizer is a full-service technology solution capable of meeting the challenge by increasing visibility into health system performance and understanding of value base care agreements. Healthcare organizations are empowered with the insight and confidence needed to deliver the best care to every patient.”

“Value Optimizer allows us to uncover opportunities quickly and easily without building a data set to see the likely impact. We can quickly drill down into the data and recommend potential interventions,” said Rich Balbach, Director, Clinical and Business Intelligence, Health Alliance Medical Plans. Health Alliance is part of the Carle Health system.

With Value Optimizer healthcare leaders can maximize every opportunity in their value-based agreements. Features include the following:

  • One comprehensive, quantified view of potential financial opportunities, enabling leaders to see and understand all financial options—up to 10,000 possible opportunities across the care continuum—benchmarked and compared with dollar impact.
  • Continually
    refreshed data and benchmarking; Value Optimizer, leverages the Health Catalyst Data Operating System (DOS™) platform to deliver timely, meaningful data to help guide the most effective VBC strategy.
  • A
    transparent view of legible groupers, metric calculations, and risk and benchmarking methodologies for a covered population. Increased visibility allows open-book analytics across 10+ population-health domains.
  • Expert guidance to maximize efficient use of the robust technology and take VBC performance to the next level. Financial leaders can collaborate with Health Catalyst experts to identify opportunities within the clinical, operational, and financial context for any population.

About Health Catalyst 
Health Catalyst is a leading provider of data and analytics technology and services to healthcare organizations committed to being the catalyst for massive, measurable, data-informed healthcare improvement. Its customers leverage the cloud-based data platform—powered by data from more than 100 million patient records and encompassing trillions of facts—as well as its analytics software and professional services expertise to make data-informed decisions and realize measurable clinical, financial, and operational improvements. Health Catalyst envisions a future in which all healthcare decisions are data informed.

Media Contact: 
Amanda Hundt 
[email protected] 
575-491-0974

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/health-catalyst-launches-value-optimizer–a-new-approach-to-managing-risk-and-achieving-profitability-in-population-health-301336631.html

SOURCE Health Catalyst

Cassava Sciences to Present New Clinical Dataset at 2021 Alzheimer’s Association International Conference

– On Monday, July 26

th

, New Clinical Data for SavaDx to be Shared in

a Poster Presentation –

– On Thursday, July 29

th

, New Clinical Data for Simufilam to be Featured in a Podium Presentation –

AUSTIN, Texas, July 21, 2021 (GLOBE NEWSWIRE) — Cassava Sciences, Inc. (Nasdaq: SAVA), a biotechnology company focused on Alzheimer’s disease, today announced it will present two new clinical datasets for its product candidates at the 2021 Alzheimer’s Association International Conference (AAIC), which is being held in Denver, Co and virtually on July 26th through July 30th. Cassava Sciences’ investigational product candidates include simufilam, a drug treatment for Alzheimer’s disease, and SavaDx, a biomarker/diagnostic to detect Alzheimer’s disease with a simple blood test.

On Monday, July 26th, at approximately 10 am ET, scientists for Cassava Sciences will show a poster presentation at AAIC, titled “SavaDx, a Novel Plasma Biomarker to Detect Alzheimer’s Disease, Confirms Mechanism of Action of Simufilam”.

On Thursday, July 29th, at approximately 11 am ET, simufilam will be featured in a live podium presentation at AAIC, including a brief Q&A session. This oral presentation will announce results of an interim analysis on safety and cognition for the first 50 patients with Alzheimer’s disease to complete 9 months of open-label treatment. Scientists for Cassava Sciences will also present biomarker data analyzed from cerebrospinal fluid (CSF) collected from 25 study subjects at baseline and again after completing 6 months of open-label drug treatment, including:

  • Biomarkers of Alzheimer’s disease: amyloid beta42, total tau, P-tau181
  • Biomarkers of neurodegeneration: neurogranin, neurofilament light chain (NfL)
  • Biomarkers of neuroinflammation: YKL-40, sTREM2 and HMGB1

“Cassava Sciences’ contributions to AAIC showcase our efforts to develop innovative product candidates for people living with Alzheimer’s disease,” said Remi Barbier, President and CEO. “We are honored AAIC’s scientific committee has invited us to present the latest clinical dataset for simufilam in an oral presentation on Thursday, July 29th.”

AAIC policy requires that all materials submitted to AAIC remain embargoed for public broadcast until their officially scheduled date and time of presentation at AAIC.

Cassava Sciences expects to publicly release all AAIC materials contemporaneously with their scheduled date and time of presentation at AAIC. At those times, materials will be posted on the ‘Investors’ page of the Company’s website: https://www.CassavaSciences.com

About SavaDx

SavaDx is Cassava Sciences’ investigational diagnostic to detect Alzheimer’s disease. The goal of SavaDx is to make the detection of Alzheimer’s as simple as getting a blood test, possibly years before the appearance of any overt clinical symptoms. SavaDx was substantially funded by a peer-reviewed research grant award from the National Institutes of Health (NIH).

About Simufilam

Simufilam (sim-uh-FILL-am) is a proprietary, small molecule (oral) drug that restores the normal shape and function of altered filamin A (FLNA), a scaffolding protein, in the brain. Altered FLNA in the brain disrupts the normal function of neurons, leading to Alzheimer’s pathology, neurodegeneration and neuroinflammation. The underlying science for simufilam is published in peer-reviewed journals, including Journal of Neuroscience, Neurobiology of Aging, Journal of Biological Chemistry, Neuroimmunology and Neuroinflammation and Journal of Prevention of Alzheimer’s Disease. Simufilam is substantially supported by peer-reviewed research grant awards from the National Institutes of Health (NIH).

About Alzheimer’s Disease

Alzheimer’s disease is a progressive brain disorder that destroys memory and thinking skills. As of 2020, there were approximately 50 million people worldwide living with dementia, a figure expected to increase to 150 million by 2050.1 The annual global cost of dementia is now above $1 trillion, according to Alzheimer’s Disease International, a charitable organization.

About AAIC
2

The Alzheimer’s Association International Conference (AAIC) is the largest and most influential international meeting dedicated to advancing dementia science. Each year, AAIC convenes the world’s leading basic science and clinical researchers, next-generation investigators, clinicians and the care research community to share research discoveries that will lead to methods of prevention and treatment and improvements in the diagnosis of Alzheimer’s disease.

About
Cassava Sciences, Inc.

Cassava Sciences’ mission is to discover and develop innovations for chronic, neurodegenerative conditions. Over the past 10 years, Cassava Sciences has combined state-of-the-art technology with new insights in neurobiology to develop novel solutions for Alzheimer’s disease.

Simufilam and SavaDx were both developed in-house. Cassava Sciences owns worldwide development and commercial rights to its research programs in Alzheimer’s disease, and related technologies, without royalty obligations to any third party.

For more information, please visit https://www.CassavaSciences.com

For More Information Contact:

Eric Schoen, Chief Financial Officer
[email protected] 
(512) 501-2450


Cautionary Note Regarding Forward-Looking Statements:


This news release contains forward-looking statements, including statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, relating to: the Company’s anticipated data presentations at AAIC; expectations regarding the clinical benefits of SavaDx or simufilam
; and
the Company’s execution on its strategy to initiate a Phase 3 clinical program in Alzheimer’s disease in 2021. These statements may be identified by words such as “may,” “anticipate,” “believe,” “could,” “expect,” “would,” “forecast,” “intend,” “plan,” “possible,” “potential,” and other words and terms of similar meaning.

Biopharmaceutical product development involves a high degree of risk, and historically only a small number of research and development programs result in commercialization of a product. Clinical results from our earlier-stage clinical trials may not be indicative of full results or results from later-stage or larger scale clinical trials and do not ensure regulatory approval. You should not place undue reliance on these statements or any scientific data we present or publish.

Such statements are based largely on our current expectations and projections about future events. Such statements speak only as of the date of this news release and are subject to a number of risks, uncertainties and assumptions, including, but not limited to, those risks relating to the ability to conduct or complete clinical studies on expected timelines, to demonstrate the specificity, safety, efficacy or potential health benefits of our product candidates, the severity and duration of health care precautions given the COVID-19 pandemic, any unanticipated impacts of the pandemic on our business operations, and including those described in the section entitled “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2020 and future reports to be filed with the SEC. The foregoing sets forth many, but not all, of the factors that could cause actual results to differ from expectations in any forward-looking statement. In light of these risks, uncertainties and assumptions, the forward-looking statements and events discussed in this news release are inherently uncertain and may not occur, and actual results could differ materially and adversely from those anticipated or implied in the forward-looking statements. Accordingly, you should not rely upon forward-looking statements as predictions of future events. Except as required by law, we disclaim any intention or responsibility for updating or revising any forward-looking statements contained in this news release.

For further information regarding these and other risks related to our business, investors should consult our filings with the SEC, which are available on the SEC’s website at


www.sec.gov


.

____________________________

1
Alzheimer’s Disease International, Dementia Statistics, available on-line and accessed July 20, 2021.
2 Source: https://www.alz.org/aaic/about/overview.asp, accessed July 19, 2021.



Bridgeline Receives More than $7.3M in Warrant Exercises

WOBURN, Mass., July 21, 2021 (GLOBE NEWSWIRE) — Bridgeline Digital, Inc. (NASDAQ: BLIN), provider of cloud-based marketing technology software, announced today it has received over $7.3M in cash, including the $2.5M previously disclosed, as a result of the recent warrant exercises. These warrants were originally issued in 2019 with a strike price of $4.00.

These funds bring Bridgeline’s cash balance to more than $9M with 8,393,609 shares of common stock outstanding. The new capital is above and beyond Bridgeline’s fully capitalized operating plan. The additional funds will be used to accelerate growth and execute Bridgeline’s eCommerce 360 strategy to drive traffic, increase conversions and grow average order value for its 2,500 customers.

“Bridgeline is fully capitalized to cover all earnout, and debt obligations from our recent two acquisitions with a strong war chest to accelerate our sales and marketing efforts as well as pursue additional strategic opportunities,” said Ari Kahn, President and CEO of Bridgeline Digital. “We thank our investors for their ongoing support.”

Bridgeline has acquired two companies in 2021, WooRank and Hawksearch. WooRank drives traffic to websites by helping improve search engine optimization. Hawksearch grows online revenues for eCommerce websites by increasing conversion and optimizing the search experience for visitors.
 
About Bridgeline Digital

Bridgeline helps companies grow online revenues by increasing their traffic, conversion rates, and average order values with its marketing platform and suite of apps. To learn more, please visit www.bridgeline.com or call (800) 603-9936.

Contact:
Danielle Erwin
VP of Marketing
Bridgeline Digital
[email protected]

 



Retail Opportunity Investments Corp. Adjusts Second Quarter Earnings Conference Call Start Time

SAN DIEGO, July 21, 2021 (GLOBE NEWSWIRE) — As previously reported, Retail Opportunity Investments Corp. (NASDAQ: ROIC) will issue financial and operational results for the second quarter ended June 30, 2021 after the market closes on Wednesday, July 28, 2021. Additionally, as previously reported, the Company will conduct a conference call and audio webcast on Thursday, July 29, 2021, now scheduled to begin at 12:00 p.m. Eastern Time / 9:00 a.m. Pacific Time.

To access the conference call, dial (877) 312-8783 (domestic), or (408) 940-3874 (international) at least ten minutes prior to the scheduled start of the call. When prompted, provide the Conference ID: 3092989. The live webcast will also be available in listen-only mode at http://www.roireit.net/.

The conference call will be recorded and available for replay beginning at 3:00 p.m. Eastern Time on July 29, 2021 and will be available until 3:00 p.m. Eastern Time on August 5, 2021. To access the conference call recording, dial (855) 859-2056 (domestic) or (404) 537-3406 (international) and use the Conference ID: 3092989. The conference call will also be archived at http://www.roireit.net/ for approximately 90 days.

ABOUT RETAIL OPPORTUNITY INVESTMENTS CORP.

Retail Opportunity Investments Corp. (NASDAQ: ROIC), is a fully-integrated, self-managed real estate investment trust (REIT) that specializes in the acquisition, ownership and management of grocery-anchored shopping centers located in densely-populated, metropolitan markets across the West Coast. As of March 31, 2021, ROIC owned 88 shopping centers encompassing approximately 10.1 million square feet. ROIC is the largest publicly-traded, grocery-anchored shopping center REIT focused exclusively on the West Coast. ROIC is a member of the S&P SmallCap 600 Index and has investment-grade corporate debt ratings from Moody’s Investor Services, Standard & Poor’s, and Fitch Ratings, Inc. Additional information is available at: www.roireit.net.

When used herein, the words “believes,” “anticipates,” “projects,” “should,” “estimates,” “expects,” “guidance” and similar expressions are intended to identify forward-looking statements with the meaning of that term in Section 27A of the Securities Act of 1933, as amended, and in Section 21F of the Securities and Exchange Act of 1934, as amended. Certain statements contained herein may constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results of ROIC to differ materially from future results expressed or implied by such forward-looking statements. Information regarding such risks and factors is described in ROIC’s filings with the SEC, including its most recent Annual Report on Form 10-K, which is available at: www.roireit.net.

Contact:
Ashley Rubino, Investor Relations
858-677-0900
[email protected]